1. Kim SH, Choi HJ, Lee SM, Yoon DS, Son CN. 2024; Effect of recombinant human bone morphogenetic protein-2 and osteoprotegerin-Fc in MC3T3-E1 cells. J Rheum Dis. 31:79–85. DOI:
10.4078/jrd.2023.0043. PMID:
38559798. PMCID:
PMC10973356.
Article
4. Okamoto M, Murai J, Yoshikawa H, Tsumaki N. 2006; Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res. 21:1022–33. DOI:
10.1359/jbmr.060411. PMID:
16813523.
Article
6. Yao Y, Wang G, Wang Z, Wang C, Zhang H, Liu C. 2011; Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. J Oral Maxillofac Surg. 69:e446–55. DOI:
10.1016/j.joms.2011.07.002. PMID:
22018252.
Article
8. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, et al. 2005; Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 8:751–64. DOI:
10.1016/j.devcel.2005.02.017. PMID:
15866165.
Article
9. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, et al. 2005; Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem. 280:21162–8. DOI:
10.1074/jbc.M501900200. PMID:
15802266.
10. Jackson A, Vayssière B, Garcia T, Newell W, Baron R, Roman-Roman S, et al. 2005; Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone. 36:585–98. DOI:
10.1016/j.bone.2005.01.007. PMID:
15777744.
Article
11. Eom YJ, Kim JW, Rim YA, Lim J, Jung SI, Ju JH. 2024; Effects of stepwise administration of osteoprotegerin and parathyroid hormone-related peptide DNA vectors on bone formation in ovariectomized rat model. Sci Rep. 14:2477. DOI:
10.1038/s41598-024-51957-0. PMID:
38291053. PMCID:
PMC10827729.
Article